{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:36:53Z","timestamp":1792773413459,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.clon.2026.104327","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:15:50Z","timestamp":1788970550000},"page":"104327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["HYPOCON: A Randomised Proof of Concept Clinical Trial of Biphasic Fractionation Schedules to Overcome Hypoxia in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Treated with Curative Intent Primary Chemo-radiotherapy"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9519-210X","authenticated-orcid":false,"given":"N.","family":"Joseph","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ajanthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Jeyakumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Rathnayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Jayawickrema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Fernandopulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8692-9804","authenticated-orcid":false,"given":"Y.","family":"Malinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bandusena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gamage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Asanthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sripali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Maddumarachchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Seneviratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Madushan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ruvinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Jeevaraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.H.D.","family":"de Zoysa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0829-9911","authenticated-orcid":false,"given":"R.G.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0779-7476","authenticated-orcid":false,"given":"S.S.","family":"Yom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clon.2026.104327_bib2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ijrobp.2019.04.023","article-title":"Clinical oncology in Sri Lanka: Embracing the promise of the future","volume":"105","author":"Joseph","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clon.2026.104327_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.clon.2026.104327_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijrobp.2025.12.056","article-title":"Hypofractionated versus normofractionated accelerated radiation therapy with or without cisplatin for locally advanced Head and Neck Squamous Cell Carcinoma (HYPNO): a randomized, open-label, phase 3, noninferiority trial","volume":"125","author":"Bentzen","year":"2026","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.clon.2026.104327_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2026.104327_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.addr.2016.10.002","article-title":"Molecular targeting of hypoxia in radiotherapy","volume":"109","author":"Rey","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"issue":"26","key":"10.1016\/j.clon.2026.104327_bib7","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1200\/JCO.2007.12.7878","article-title":"Hypoxic radiosensitization: adored and ignored","volume":"25","author":"Overgaard","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clon.2026.104327_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-8140(97)00220-X","article-title":"A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85","volume":"46","author":"Overgaard","year":"1998","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clon.2026.104327_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/oxfordjournals.bmb.a070953","article-title":"Exploitation of the oxygen enhancement ratio in clinical practice","volume":"29","author":"Duncan","year":"1973","journal-title":"Br Med Bull"},{"issue":"31","key":"10.1016\/j.clon.2026.104327_bib10","doi-asserted-by":"crossref","first-page":"50781","DOI":"10.18632\/oncotarget.9549","article-title":"Current relevance of hypoxia in head and neck cancer","volume":"7","author":"Bredell","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.clon.2026.104327_bib11","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s00259-016-3429-y","article-title":"Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer","volume":"43","author":"Zegers","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clon.2026.104327_bib12","series-title":"Advances in radiation Biology","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/B978-0-12-035405-4.50012-8","article-title":"The four R's of radiotherapy","author":"Withers","year":"1975"},{"issue":"1","key":"10.1016\/j.clon.2026.104327_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijrobp.2008.10.049","article-title":"Prospective trial incorporating pre-\/mid-treatment [18F]-Misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy","volume":"75","author":"Lee","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clon.2026.104327_bib14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0360-3016(01)01686-8","article-title":"Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlateswith reoxygenation","volume":"51","author":"Petersen","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.clon.2026.104327_bib15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.4103\/jcrt.JCRT_511_19","article-title":"Correlation of planning target volume with mucositis for head-and-neck cancer patients undergoing chemoradiation","volume":"16","author":"Manur","year":"2020","journal-title":"J Cancer Res Ther"},{"issue":"1","key":"10.1016\/j.clon.2026.104327_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.radonc.2016.05.017","article-title":"Influence of dosimetric and clinical criteria on the requirement of artificial nutrition during radiotherapy of head and neck cancer patients","volume":"120","author":"Matuschek","year":"2016","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.clon.2026.104327_bib17","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1016\/j.clon.2017.02.002","article-title":"Dysphagia-optimised Intensity-modulated radiotherapy techniques in pharyngeal cancers: is anyone going to swallow it?","volume":"29","author":"Petkar","year":"2017","journal-title":"Clin Oncol"},{"issue":"10166","key":"10.1016\/j.clon.2026.104327_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"issue":"1112","key":"10.1016\/j.clon.2026.104327_bib19","article-title":"Radiobiologically derived biphasic fractionation schemes to overcome the effects of tumour hypoxia","volume":"93","author":"Joseph","year":"2020","journal-title":"Br JRadiol"},{"key":"10.1016\/j.clon.2026.104327_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2020.07.037","article-title":"The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines","volume":"151","author":"Jensen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2026.104327_bib21","series-title":"Head and neck oropharynx squamous cell carcinoma definitive EBRT chemoradiation (Protocol ID: 3362, Version 4). eviQ","year":"2026"},{"key":"10.1016\/j.clon.2026.104327_bib22","series-title":"Randomization for block random clinical trials [Software]. R package version 1.5","author":"Snow","year":"2020"},{"key":"10.1016\/j.clon.2026.104327_bib23","series-title":"Wiley Encyclopedia of clinical trials","article-title":"Sample size calculation for comparing proportions","author":"Wang","year":"2007"},{"issue":"2","key":"10.1016\/j.clon.2026.104327_bib24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jclinepi.2012.09.002","article-title":"Sample size calculations for pilot randomized trials: A confidence interval approach","volume":"66","author":"Cocks","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clon.2026.104327_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2288-14-41","article-title":"The statistical interpretation of pilot trials: Should significance thresholds be reconsidered?","volume":"14","author":"Lee","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.clon.2026.104327_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105032","article-title":"A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trl","volume":"101","author":"Smith","year":"2024","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.clon.2026.104327_bib27","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.clon.2026.104327_bib28","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1136\/ijgc-2021-002806","article-title":"Impact of hypoxia on cervical cancer outcomes","volume":"31","author":"Datta","year":"2021","journal-title":"Int J Gynecol Cancer"},{"issue":"12","key":"10.1016\/j.clon.2026.104327_bib29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.clon.2021.09.017","article-title":"Curative-intent radiotherapy for squamous cell carcinoma of the head and neck in Sri Lanka: the impact of radiotherapy technique on survival","volume":"33","author":"Rupasinghe","year":"2021","journal-title":"Clin Oncol (R Coll Radiol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526002980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526002980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:05:51Z","timestamp":1792767951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655526002980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":28,"alternative-id":["S0936655526002980"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2026.104327","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HYPOCON: A Randomised Proof of Concept Clinical Trial of Biphasic Fractionation Schedules to Overcome Hypoxia in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Treated with Curative Intent Primary Chemo-radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2026.104327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104327"}}